机构：[1]Jinan University, Guangzhou, Guangdong, China.[2]Fuda Cancer Hospital Affiliated to Jinan University, Guangzhou, Guangdong, China.[3]Ruikang Hospital, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
With the progress of molecular diagnosis research on non-small cell lung cancer (NSCLC) cells, four identified categories of microRNAs have been found to be related to disease diagnosis, diagnosis of treatment resistance, prediction of prognosis, and drugs for treatment. To date, nine target mRNA/signal pathways have been confirmed for microRNA drug therapy both in vitro and in vivo. When microRNA drugs enter blood vessels, they target the tumor site and play a similar role to that of targeted drugs. However, whether they will produce serious off-target effects remains unknown, and further clinical research is needed. This review provides the first summary of microRNA therapy for NSCLC.
基金：
Guangzhou Science and
Technology Plan (grant number 202102010059), the Guangxi
Chinese Medicine Administration Special Fund for Chinese
Medicine Inheritance and Innovation Development (Construction of
Translational Medicine Center of Ruikang Hospital 2023), and the
Guangxi Science and Technology Base and Talent Project (grant
number AD22035122).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类|4 区医学
小类|4 区肿瘤学
最新[2025]版：
大类|4 区医学
小类|4 区肿瘤学
第一作者：
第一作者机构：[1]Jinan University, Guangzhou, Guangdong, China.[2]Fuda Cancer Hospital Affiliated to Jinan University, Guangzhou, Guangdong, China.[3]Ruikang Hospital, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
共同第一作者：
通讯作者：
通讯机构：[3]Ruikang Hospital, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.[*1]Ruikang Hospital Affiliated to Guangxi University of Traditional Chinese Medicine, No. 10 of Huadong Road, Xingning District, 530011 Nanning, Guangxi, China.
推荐引用方式(GB/T 7714)：
Chen Jibing,Wu Fasheng,Hou Encun,et al.Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer[J].Technology in cancer research & treatment.2023,22:15330338231210731.doi:10.1177/15330338231210731.
APA：
Chen Jibing,Wu Fasheng,Hou Encun,Zeng Jianying,Li Fujun&Gao Hongjun.(2023).Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer.Technology in cancer research & treatment,22,
MLA：
Chen Jibing,et al."Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer".Technology in cancer research & treatment 22.(2023):15330338231210731
